The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Share News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.65
Bid: 16.00
Ask: 19.40
Change: 0.00 (0.00%)
Spread: 3.40 (21.25%)
Open: 17.65
High: 0.00
Low: 0.00
Prev. Close: 17.65
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: TP chair resigns amid pressure from Science Group

Fri, 29th Oct 2021 15:57

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and Friday and not separately reported by Alliance News:

----------

TP Group PLC - Wincanton, England-based consulting, software and engineering company - Philip Holland resigns as chair, effective immediately, having served for four years. Holland "made this decision in the best interests of the TP Group's employees and shareholders in order to enable the company to move forward with a new strategy", TP says. Science Group PLC, a 27% shareholder of TP, on Tuesday had requisitioned a general meeting to remove Holland, who had stepped up to chair in late September to replace Andrew McCree. Earlier this month, Martyn Ratcliffe and Peter Bertram joined the TP board to represent Science Group, which had failed in a hostile takeover offer for TP Group back in August.

----------

Futura Medical PLC - Guildford, Surrey-based pharmaceutical products for sexual health and pain - Hires Andrew Unitt as non-executive director, starting January 1. Unitt replaces Jonathan Freeman, who steps down as senior independent non-executive director on December 31. Unitt was with pharmacy chain Boots PLC for 11 years, including four as finance director of Boots Healthcare International, its over-the-counter medicines business. He currently is a non-executive director of AIM-listed diagnostics firm Oncimmune Holdings PLC.

----------

Baillie Gifford Shin Nippon PLC - invests for capital growth from small Japanese companies - Hires Claire Finn and Abigail Rotheroe as non-executive directors, with Finn starting on November 1 and Rotheroe on March 1 next year. Finn, a former executive at BlackRock Inc, is a director of London-listings Law Debenture Corp PLC and Octopus Apollo VCT PLC. Rotheroe is investment director for Snowball Impact Management, an asset manager focused on socially responsible investment. Rotheroe previously worked for Threadneedle Investments, managing Asia- and Japan-focused funds.

----------

Resolute Mining Ltd - Perth, Australia-based gold miner with projects in Mali, Senegal and Guinea - Hires Simon Jackson as non-executive director, starting Friday. Jackson replaces Yasmin Broughton, who resigned on Thursday, having served since 2017. Jackson has over 25 years experience managing mining companies, Resolute said, currently serving on several boards, including two as chair.

----------

Capital Metals PLC - mineral sands project in Sri Lanka - Hires James Mahony as chief financial officer, effective immediately, while Anthony Samaha steps down as finance director. Mahony is a partner in Westend Corporate LLP, which provides financial consulting and corporate management services. Additionally, Westend will take over as company secretary, replacing Sam Quinn.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
4 Mar 2020 12:57

Oncimmune EarlyCDT Lung Test Launched In US By Commercial Partner

Oncimmune EarlyCDT Lung Test Launched In US By Commercial Partner

Read more
12 Feb 2020 09:10

Oncimmune Half-Year Loss Widens As Business "Reshaping" Ups Expenses

Oncimmune Half-Year Loss Widens As Business "Reshaping" Ups Expenses

Read more
28 Jan 2020 13:52

Oncimmune Reports Study Results For Cancer Test Product

Oncimmune Reports Study Results For Cancer Test Product

Read more
22 Nov 2019 16:05

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
1 Nov 2019 13:33

Oncimmune And Biodesix Complete US Agreement For Lung Cancer Test

Oncimmune And Biodesix Complete US Agreement For Lung Cancer Test

Read more
31 Oct 2019 11:38

Oncimmune Annual Loss Deepens On Costs But Makes Operational Progress

Oncimmune Annual Loss Deepens On Costs But Makes Operational Progress

Read more
25 Sep 2019 11:32

CORRECT (Sep 20): Oncimmune Secures EUR8.5 Million Credit Facility

CORRECT (Sep 20): Oncimmune Secures EUR8.5 Million Credit Facility

Read more
23 Sep 2019 16:08

Oncimmune Adds Former Glaxo And Astra Seniors To Leadership Ranks

Oncimmune Adds Former Glaxo And Astra Seniors To Leadership Ranks

Read more
20 Sep 2019 15:47

Oncimmune funded into 2021 with new EUR 8.5m facility

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has secured a credit facility of €8.5m (£7.5m) with IPF Management, it announced on Friday.

Read more
20 Sep 2019 14:04

Oncimmune Secures EUR8.5 Billion Debt For Products Commercialisation

(Alliance News) - Oncimmune Holdings PLC on Friday said it has secured a credit facility of EUR8.5 million with IPF Management SA.The immunodiagnostics company said it will immediately draw

Read more
9 Sep 2019 12:07

Oncimmune "Thrilled" With EarlyCDT Lung Cancer Test Trial Result

(Alliance News) - Oncimmune Holdings PLC on Monday announced positive results from a trial of its EarlyCDT Lung test to detect early stage lung cancer.Shares in Oncimmune were up 5.5% at in

Read more
15 Jul 2019 12:55

Oncimmune Further Expands EarlyCDT Lung Sales In Spain Through Vithas

(Alliance News) - Oncimmune Holdings PLC on Monday said Sabartech SL, its existing distributor in Spain and Portugal, has agreed with Vithas Group to sell EarlyCDT Lung as a screening test for of

Read more
28 Jun 2019 11:03

Oncimmune sells US operations to and partners with Biodesix

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has entered into an exclusive partnership agreement, it announced on Friday, which it said could "unlock the full potential" of its 'EarlyCDT Lung' product in the United States.

Read more
26 Jun 2019 10:58

Oncimmune confident of 'material profitable revenues'

(Sharecast News) - Immunodiagnostics firm Oncimmune told investors on Wednesday it was confident it could generate "material profitable revenues" on the back of several business developments.

Read more
4 Jun 2019 09:56

Oncimmune Holdings Reports Positive Lung Cancer Study Results

LONDON (Alliance News) - Oncimmune Holdings PLC on Tuesday reported positive top line results from its early cancer detection test in patients with lung cancer.Oncimmune Holdings shares at

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.